THYROID EYE DISEASE

This study tested whether a new antibody drug called LASN01 can help people with moderate-to-severe thyroid eye disease. Forty-one patients received either the drug or a placebo to see if it reduces eye bulging and inflammation. The trial specifically looked at patients who hadn'…

This international study tested whether shorter or longer treatment courses with the drug teprotumumab are safe and effective for adults with Thyroid Eye Disease. Researchers compared three different treatment durations in 313 participants to see how well they controlled eye symp…

This study tested whether an experimental drug called IBI311 could safely reduce eye bulging and inflammation in people with thyroid eye disease. Thirty-eight adults with either active or inactive forms of the condition received different doses of the drug or a comparison. Resear…

This study looked back at medical records to see how well the drug teprotumumab worked for people with Thyroid Eye Disease (TED) in China. Researchers checked if the treatment reduced eye bulging (proptosis) and improved other symptoms for 5 patients who received it. The goal was…

This study gave continued access to an experimental drug called VRDN-001 to people with thyroid eye disease who did not improve enough in previous trials. The goal was to see if longer treatment could help reduce eye bulging and double vision, and to check the drug's safety. It i…

This completed Phase 3 trial tested whether weekly injections of an experimental drug called batoclimab could reduce eye bulging (proptosis) and inflammation in people with active Thyroid Eye Disease. The study involved 114 adults who received either the drug or a placebo for 24 …

This study tested the safety of an experimental drug called VRDN-001 for people with thyroid eye disease, a condition that causes eye inflammation and swelling. The trial involved 231 participants and was designed to see how well people tolerate the treatment and what side effect…

This study tested whether a new drug called veligrotug could safely reduce eye bulging and other symptoms in people with chronic thyroid eye disease. 188 participants received either the drug or a placebo through IV infusions over 12 weeks. Researchers measured changes in eye pro…

This small, completed study tested the safety of aflibercept injections around the eye in people with active Thyroid Eye Disease. The goal was to see if this drug, which blocks a protein that causes swelling, could safely reduce eye inflammation, bulging, and double vision. Eleve…